alltrials

Showing 15 posts of 36 posts found.

bens1

AllTrials puts FDA under pressure with Trials Tracker

February 22, 2018
Medical Communications alltrials, biotech, drugs, pharma, pharmaceutical

A year to the day that the FDA unveiled its Final Rule, which sees organisation given 13 months from clinical …

Scales of justice

Judge rules pharma has ‘ethical’ transparency obligation – reaction

July 29, 2015
Research and Development Ben Goldacre, Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, sense about science, transparency

Both sides of a bitterly contested legal battle over a major part of the industry’s transparency drive have reacted to …

It’s time the industry spoke out about legal challenge to clinical trial transparency

July 16, 2015
Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency

The judicial review brought by Richmond Pharmacology against the Health Research Authority – erroneous, a waste of public money and …

Industry awaits outcome of transparency legal challenge

July 16, 2015
Research and Development Richmond Pharmacology, alltrials, clinical trials, health research authority, hra, judicial review, legal challenge, sense about science, transparency

A judge will today hear arguments from the Health Research Authority and campaigners who are contesting a judicial review of …

World Health Organisation calls for full trial transparency

April 14, 2015
Research and Development, Sales and Marketing Ben Goldacre, EU, WHO, World Health Organisation, alltrials, clinical trials, sense about science, transparency

The World Health Organization has thrown its weight behind clinical trial transparency in a new statement on its position. WHO …

Tamiflu image

Government spending on Tamfilu is justified

January 30, 2015
Research and Development, Sales and Marketing BMJ, Lancet, Roche, Tamiflu, alltrials, oseltamivir, transparency

The most thorough analysis of Roche’s Tamiflu to date suggests that the controversial treatment can shorten the duration of flu …

EMA image

EMA launches consultation on clinical trials

January 22, 2015
Research and Development, Sales and Marketing EFPIA, EMA, EU, Europe, Goldacre, alltrials, transparency

The European Medicines Agency has invited pharma to comment on its proposals to ramp up transparency in the industry and …

ABPI image

Pharma and transparency: actions speak louder than words

October 13, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, UK, alltrials, andrew powrie-smith, hcp, transparency

As an industry we continue to deliver innovative, life changing medicines and rewrite the story of many diseases, yet our …

EMA image

Mixed response to EMA data transparency plans

October 3, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, BMJ, Ben Goldacre, EMA, alltrials, transparency

The European Medicines Agency has passed new rules that will mandate pharma to release more of its clinical trial data …

NICE seeks more trial data from pharma

September 10, 2014
Medical Communications, Research and Development, Sales and Marketing David Haslam, NICE, Tamiflu, alltrials, transparency

NICE is calling on pharma to release more data so it can better assess the costs of new medicines.The watchdog …

Jane Griffiths, company group chairman for Janssen EMEA and chairwoman of the EF

Janssen: why transparency is essential to the health of our industry

August 29, 2014
Medical Communications, Research and Development, Sales and Marketing EFPIA, EMEA, Goldacre, Janssen, alltrials, transparency

The pharmaceutical industry is moving forward, working together to ensure patients have access to new and innovative medicines.However, more must …

ema image

EMA delays trial transparency – again

July 10, 2014
Medical Communications, Research and Development, Sales and Marketing EMA, Goldacre, Rasi, alltrials, clinical trials, transparency

The European Medicines Agency has once again said that it is to delay the launch of its new clinical trial …

EMA image

EMA changes ‘on screen’ data policy

June 16, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, EMA, Goldacre, Humira, alltrials, transparency

The European Medicines Agency is to formally agree its policy on the vexed issue of the publication of clinical trial …

Latest content